Navigation Links
Attorney General Corbett Announces $36.7 Million Multi-State Settlement With CVS/Caremark in National Dosage-Switching Investigation
Date:3/18/2008

HARRISBURG, Pa., March 18 /PRNewswire-USNewswire/ -- Attorney General Tom Corbett today announced a $36.7 million multi-state settlement with CVS/Caremark Corporation, a Rhode Island-based pharmacy chain, resolving allegations that the company improperly billed state and federal Medicaid programs by switching the form of dosage for a commonly prescribed anti-ulcer medication.

Corbett said the settlement follows a joint federal and state investigation concerning prescriptions filled by CVS/Caremark for the antacid medicine ranitidine, the generic form of Zantac. Between 1999 and 2006, CVS pharmacies allegedly substituted a more-expensive capsule form of the drug, rather than tablets, resulting in higher payments by Medicaid with no medical benefit to patients.

According to the settlement, CVS was accused of making wholesale changes in the dosage form for ranitidine prescriptions without the involvement of patients' doctors, violating numerous state regulations governing the dispensing of drugs.

Corbett said that Pennsylvania will receive $495,628 from CVS/Caremark as the result of this settlement. The payment will be used to reimburse the PA Medicaid program for higher prescription payments that were generated by the switch from ranitidine tablets to capsules.

Corbett said the multi-state settlement also requires CVS/Caremark to adopt a "Corporate Integrity Agreement," ensuring the company will not switch dosage forms of medications if that change would result in higher costs for Medicaid and other prescription programs. The billing practices for CVS will also be subject to ongoing federal scrutiny.

The settlement with CVS/Caremark includes Pennsylvania, along with Alabama, Connecticut, Florida, Georgia, Illinois, Indiana, Kentucky, Maine, Maryland, Massachusetts, Michigan, New Hampshire, New Jersey, New York, North Carolina, Ohio, Rhode Island, South Carolina, Tennessee, Vermont, Virginia and West Virginia, as well as the District of Columbia and the federal government.

The settlement was the result of joint negotiations involving the U.S. Attorney's Office and the National Association of Medicaid Fraud Control Units.

CONTACT: Nils Frederiksen, Deputy Press Secretary for Pennsylvania Attorney General Corbett, +1-717-787-5211, or cell, +1-717-319-2252, nhf@attorneygeneral.gov


'/>"/>
SOURCE Pennsylvania Office of Attorney General
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Cardinal Health Names Former Acting Deputy U.S. Attorney General Craig S. Morford to Chief Compliance Officer Post
2. Empire Blue Cross Blue Shield Statement in Response to New York Attorney Generals Recent Subpoenas
3. TransUnion Addresses Ohio Attorney Generals Concerns Surrounding Non-Profit Tax-Exempt Status
4. Anapol Schwartz Attorney Representing Trasylol(R) Victims Says Medical Study - Confirming Heart Bypass Drug Mortality Risk - to Open Floodgates for More Litigation
5. Pennsylvania Attorney General Corbett Announces Multi-State Settlement With Caremark
6. AHIP Statement on New York Attorney Generals Announcement
7. Pennsylvania Attorney General Approves Vincentian Collaborative System-Marian Manor Integration
8. Former FTC Attorney Christine White Joins Crowell & Morings Health Care and Antitrust Groups
9. Elder Care Operator and Plaintiff Attorney Announce Unprecedented Settlement Agreement in Class Action Lawsuit
10. Statement from AAJ President Kathleen Flynn Peterson on ATRAs Latest Attack on Civil Justice Attorneys
11. Famed Attorney Willie Gary Files $10.6 Billion in Lawsuits against Big Tobacco Companies on Behalf of Florida Smokers and their Families
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... American orthopedic surgeon ... officer of Blue Horizon International (BHI), Brian Mehling, M.D., spoke at an International ... May 5-6, 2016 in Chicago, IL, USA. Dr. Mehling’s presentation was focused on ...
(Date:5/26/2016)... ... 26, 2016 , ... Bunion Bootie , the manufacturer of the newest ... than humbled by customer demand over the Mother’s Day Weekend promotion. So much so, ... Bunion Bootie has completely replenished its inventory levels, it hopes to continue its current ...
(Date:5/26/2016)... ... May 26, 2016 , ... The introduction of our professional athletes coincides with ... ™”. , “We are proud to introduce Meghan Klingenberg, defender and World ... Brian Quick, wide receiver for Los Angeles who was a second round selection in ...
(Date:5/26/2016)... York, NY (PRWEB) , ... May 26, 2016 , ... ... have lips been so central to popular cosmetic improvement efforts. Record numbers of clients ... kissers appear more prominent or pouty, says Kally Papantoniou, MD, of Advanced Dermatology ...
(Date:5/26/2016)... ... 2016 , ... Development Team of Pixel Film Studios Announced The Release of ... style transition tool will keep a consistent flow to your project while adding interesting ... , TranSweep is an all new layered style transition tool for Final Cut ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... HONG KONG , May 24, 2016 /PRNewswire/ ... primer stent de doble terapia del mundo, introduce ... fístula arteriovenosa. OrbusNeich, una compañía global ... cambian las vidas, ha expandido su cartera incluyendo ... catéteres balón JADE™ y Scoreflex™ PTA son los ...
(Date:5/24/2016)... -- Een app die artsen over de ... kunnen behandelen, hun kennis kunnen delen en van elkaar ... en revolutionaire MDLinking App, ontwikkeld door een internationale groep ... Flu en oncologisch chirurg dr. Gijs van Acker ... op dinsdag 24 mei officieel gepresenteerd op het Amsterdam ...
(Date:5/23/2016)... May 23, 2016 Transparency Market ... Exocrine Pancreatic Insufficiency Market - Global Industry Analysis, Size, ... According to the report, the exocrine pancreatic insufficiency market ... from 2015 to 2023 to reach US$2.85 Bn by ... condition characterized by the deficiency of the exocrine pancreatic ...
Breaking Medicine Technology: